These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2487381)

  • 41. Purification and characterisation of the fourth component of bovine complement.
    Groth DM; Wetherall JD; Umotong BA; Sparrow P; Lee IR; Carrick MJ
    Complement; 1987; 4(1):1-11. PubMed ID: 3568627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered differentiation of limb bud cells by transforming growth factors-beta isolated from bone matrix and from platelets.
    Schönfeld HJ; Pöschl B; Wessner B; Kistler A
    Bone Miner; 1991 Jun; 13(3):171-89. PubMed ID: 1650618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of a low molecular weight form of epithelial transforming growth factor.
    Dunnington D; Prichett W; Moyer M; Greig R
    Life Sci; 1990; 47(22):2059-63. PubMed ID: 2273942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification and properties of epithelial growth inhibitor (EGI) from human platelets: its separation from type beta transforming growth factor (TGF-beta).
    Huang W; Kimura T; Mashima K; Miyazaki K; Masaki H; Yamashita J; Horio T
    J Biochem; 1986 Sep; 100(3):687-96. PubMed ID: 3465720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification of macrophage deactivating factor.
    Srimal S; Nathan C
    J Exp Med; 1990 Apr; 171(4):1347-61. PubMed ID: 2109038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcium binding proteins: purification of hepatocalcin-55 from bovine liver.
    Gültekin H; Horitsu K; Domagk GF
    Int J Biochem; 1987; 19(8):671-7. PubMed ID: 3622899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An improved method of purification of transforming growth factor, type beta from platelets.
    Cone JL; Brown DR; DeLarco JE
    Anal Biochem; 1988 Jan; 168(1):71-4. PubMed ID: 3163238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human transforming growth factor type beta 2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization.
    Ikeda T; Lioubin MN; Marquardt H
    Biochemistry; 1987 May; 26(9):2406-10. PubMed ID: 3475130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Partial purification and characterization of masking protein for beta-type transforming growth factor from rat platelets.
    Nakamura T; Kitazawa T; Ichihara A
    Biochem Biophys Res Commun; 1986 Nov; 141(1):176-84. PubMed ID: 3541925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming growth factor beta and a mesoderm inducing factor from human blood platelets are different proteins.
    Dau H; Wedlich D; Born J; Loppnow-Blinde B; Tiedemann H; Tiedemann H
    FEBS Lett; 1990 Oct; 273(1-2):68-70. PubMed ID: 2226866
    [No Abstract]   [Full Text] [Related]  

  • 51. Purification of transforming growth factors beta 1 and beta 2 from bovine bone and cell culture assays.
    Ogawa Y; Seyedin SM
    Methods Enzymol; 1991; 198():317-27. PubMed ID: 1857225
    [No Abstract]   [Full Text] [Related]  

  • 52. Purification of an acid-stable bovine leukocyte interferon.
    Abolhassani M; Jacobsen KL
    Vet Immunol Immunopathol; 1991 Aug; 29(1-2):171-81. PubMed ID: 1949578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bovine colostric transforming growth factor-beta-like peptide that induces growth inhibition and changes in morphology of human osteogenic sarcoma cells (MG-63).
    Tokuyama H; Tokuyama Y
    Cell Biol Int Rep; 1989 Mar; 13(3):251-8. PubMed ID: 2706687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation and partial characterization of a high molecular weight anionic glycoconjugate from transforming growth factor-beta treated bovine articular chondrocyte cultures.
    Chan CK; Anastassiades TP
    Biochem Cell Biol; 1996; 74(2):233-40. PubMed ID: 9213432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation and characterisation of milk growth factor, a transforming-growth-factor-beta 2-related polypeptide, from bovine milk.
    Cox DA; Bürk RR
    Eur J Biochem; 1991 Apr; 197(2):353-8. PubMed ID: 2026157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production and characterization of bovine interleukin-2.
    Namen AE; Magnuson JA
    Immunology; 1984 Jul; 52(3):469-75. PubMed ID: 6611295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneity of pregnancy-specific beta 1-glycoprotein following purification from maternal serum and partial characterization of a high-molecular-weight component.
    Griffiths BW; Godard A
    J Reprod Immunol; 1981 Jun; 3(2):117-29. PubMed ID: 6974239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation and partial characterization of a cystine-rich basic heparin-binding protein from bovine platelets.
    Szabó E; Muszbek L
    Biochem Biophys Res Commun; 1991 Jan; 174(1):70-6. PubMed ID: 1989621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glia maturation factor in bovine brain: partial purification and physicochemical characterization.
    Kato T; Fukui Y; Turriff DE; Nakagawa S; Lim R; Arnason BG; Tanaka R
    Brain Res; 1981 May; 212(2):393-402. PubMed ID: 7225875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The basic proteins of bovine allantoic fluid.
    Lambert PP; Lammens-Verslijpe M; Sennesael J; Herremans N; Delsaux B
    Biol Reprod; 1987 Nov; 37(4):887-99. PubMed ID: 3689855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.